Increase in Focus Of Key Players Is Boosting The Demand Structural Heart Devices Market

Structural Heart Devices Market


Structural heart disease (SHD) refers to a wide category of percutaneous treatments for the patients with both acquired heart disease and congenital heart disease (CHD) that involves functional and structural abnormalities of cardiac chambers, proximal great vessels, and heart valves.

Drivers & Restraints

The global market is anticipated to rise at a considerable rate during the forecast period. In the recent years, the market was growing at a steady rate and with the rising adoption of strategies by key players; the market is expected to rise over the projected horizon. Rise in incidence of structural heart diseases, technological advancements, and increase in demand for minimally invasive techniques are factors that drive the structural heart devices market.

Sample Link Here:




Heart Repair Devices

Replacement Valves



Atrial Septal Defect (ASD)

Patent Foramen Ovale (PFO)

Ventricular Septal Defect (VSD)

Aortic Valve Stenosis


Regional Analysis

The market has been segment into North America, South America, Europe, Asia-Pacific, and Middle East and Africa. North America dominated by market share in 2016 and is followed by Europe.

Purchase Link Here:



Medtronic plc

St. Jude Medical, Inc.

Braile Biomedica

Medical Technology Est.

Boston Scientific Corporation

Micro Interventional Devices, Inc.

Edwards Lifesciences Corporation

LivaNova PLC

JenaValve Technology, Inc.